© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Michael Mauro Discusses Therapy-Free CML Remission
December 31, 2015
Michael Mauro, MD
Michael Mauro, MD
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Mauro says patients with CML are often concerned about how long they have to stay on medication.
Related Content: